切迫性および混合性尿失禁を有する女性患者に対するイミダフェナシンの臨床的有用性の検討

概要

The effect of imidafenacin for the treatment of overactive bladder (OAB), in female patients with urge and mixed urinary incontinence was examined. Prior to administration and at 1, 2, 3, 4, 6, 8, 10 and 12 weeks after administration, symptoms and quality of life were assessed using the overactive bladder symptom score (OABSS) and the international consultation on incontinence questionnaire-short form (ICIQ-SF), respectively. After administration, OABSS and ICIQ-SF scores were improved significantly when compared to baseline values. The incidence of adverse events was 7. 9% and none were serious. Imidafenacin was effective in female patients with urge and mixed urinary incontinence. In addition, imidafenacin rapidly improved incontinence one week after administration.

著者

島田 誠 昭和大学横浜市北部病院泌尿器科
井上 克己 昭和大学横浜市北部病院泌尿器科
島田 誠 昭和大
奥村 太輔 昭和大学医学部泌尿器科学講座
奥村 太輔 昭和大学藤が丘病院泌尿器科

関連論文

▼もっと見る